As shown in Figure 5B, PCNA protein expression was significantly (p < 0.05) inhibited at a rate of 32% in the RTP-H treatment group compared to the tumor group, while the inhibitory effects were not significant (p > 0.05) in the RTP-L treatment group. The gene discussed is PCNA; the disease is neoplasm.